These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21362684)

  • 1. Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial.
    Mochtar MH; Custers IM; Koks CA; Bernardus RE; Verhoeve HR; Mol BW; van Wely M; van der Veen F
    Hum Reprod; 2011 May; 26(5):1091-6. PubMed ID: 21362684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.
    Ragni G; Vegetti W; Riccaboni A; Engl B; Brigante C; Crosignani PG
    Hum Reprod; 2005 Sep; 20(9):2421-5. PubMed ID: 15890731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.
    Baerwald A; Anderson P; Yuzpe A; Case A; Fluker M
    Fertil Steril; 2012 Oct; 98(4):881-7.e1-2. PubMed ID: 22819187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation.
    van der Houwen LE; Mijatovic V; Leemhuis E; Schats R; Heymans MW; Lambalk CB; Hompes PG
    Reprod Biomed Online; 2014 Jan; 28(1):39-46. PubMed ID: 24262434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.
    Moraloglu O; Kilic S; Karayalçin R; Yuksel B; Tasdemir N; Işik A; Ugur M
    Adv Ther; 2008 Mar; 25(3):266-73. PubMed ID: 18345521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
    Ata B; Yakin K; Balaban B; Urman B
    Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial.
    Morley L; Tang T; Yasmin E; Hamzeh R; Rutherford AJ; Balen AH
    Hum Fertil (Camb); 2012 Sep; 15(3):134-9. PubMed ID: 22812907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial.
    Cédrin-Durnerin I; Guivarc'h-Levêque A; Hugues JN;
    Fertil Steril; 2012 Jun; 97(6):1359-64.e1. PubMed ID: 22464760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three protocols for monitoring follicle development in 587 unstimulated cycles of in vitro fertilization and intracytoplasmic sperm injection. A comparison.
    Vlaisavljević V; Kovacic B; Reljic M; Lovrec VG
    J Reprod Med; 2001 Oct; 46(10):892-8. PubMed ID: 11725733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.
    Haydardedeoglu B; Kilicdag EB; Parlakgumus AH; Zeyneloglu HB
    Arch Gynecol Obstet; 2012 Sep; 286(3):763-9. PubMed ID: 22569710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C; Lindenberg S;
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
    Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
    Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.
    Lee JR; Choi YS; Jee BC; Ku SY; Suh CS; Kim KC; Lee WD; Kim SH
    Fertil Steril; 2007 Nov; 88(5):1344-9. PubMed ID: 17548083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.